Propanc Biopharma, Inc. Common Stock (PPCB) financials · $3.9M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Propanc Biopharma, Inc. Common Stock (PPCB) $3.9M cap.
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Income | -$18.2M | -$57.3M |
| Net Income | -$18.9M | -$58.9M |
| EPS (Diluted) | -$17.62 | -$14.85 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $12.8M | $19.6M |
| Current Assets | $8.54M | $8.35M |
| Cash & Equivalents | $832.0K | $12.1K |
| PP&E | $3.92K | $25.1K |
| Total Liabilities | $3.38M | $5.73M |
| Current Liabilities | $3.35M | $5.58M |
| Long-term Debt | N/A | $537.9K |
| Total Debt | N/A | $537.9K† |
| Shareholders' Equity | $9.40M | $13.9M |
| Retained Earnings | -$144.5M | -$125.6M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$5.68M | -$405.2K |
| CapEx | $4.93K | N/A |
| Investing Cash Flow | -$4.93K | N/A |
| Financing Cash Flow | $6.46M | $490.8K |
| Net Change in Cash | $819.9K | -$9.00K |
| Free Cash Flow | -$5.69M | N/A |
FAQ
What is PPCB P/E and revenue?
Propanc Biopharma, Inc. Common Stock (PPCB) $3.9M cap.
What is PPCB revenue?
PPCB income-statement cache has no revenue figure yet.
Is PPCB profitable?
Propanc Biopharma, Inc. Common Stock last cached net income is -$18.9M (FY2026).
What are PPCB total assets?
Propanc Biopharma, Inc. Common Stock last cached total assets are $12.8M (FY2026).
What is PPCB free cash flow?
Propanc Biopharma, Inc. Common Stock last cached free cash flow is -$5.69M (FY2026).
Not investment advice. Cached statements, not a live tape.